Skip to content

Feasibility RCT of ACT Self-help for Depression in Haemodialysis

Acceptance and Commitment Therapy Self-help Intervention for Depression in Haemodialysis Patients: A Feasibility Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02565056
Enrollment
9
Registered
2015-10-01
Start date
2015-01-31
Completion date
2016-04-30
Last updated
2016-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, End-stage Renal Disease

Keywords

Acceptance and Commitment Therapy

Brief summary

The purpose of this study is to assess the feasibility of conducting a trial to evaluate a self-help treatment for depression in people with end-stage renal disease.

Detailed description

Chronic Kidney Disease (CKD) is a long-term condition in which the function of the kidneys - to filter out waste products from the blood - slowly declines. When renal function becomes sufficiently low it is described as End Stage Renal Disease (ESRD) and renal replacement therapy (RRT) is likely to be needed to prolong life. The most common type of RRT is haemodialysis, in which the patient's blood is filtered through a machine. It is estimated that depression is experienced by 20-40% of people with ESRD. Depression not only affects the quality of life of individuals with ESRD but is also associated with higher rates of hospitalisation and poorer physical health outcomes. Acceptance and Commitment Therapy (ACT) has been found to be an effective treatment for depression and has been used successfully as a self-help treatment. However, no study has examined the effectiveness of an ACT self-help treatment for depression in ESRD. This study aims to assess the feasibility of conducting such a study and will look at suitability of recruitment, assessment methods and the acceptability of the self-help treatment, as well as helping to calculate the number of people needed for a definitive study. Haemodialysis patients receiving dialysis through an NHS renal service will be invited to participate. To participate they will be consenting, over 18 years of age and experiencing depressive symptoms at a clinical level. Those eligible will be randomly assigned into one of two conditions; a control condition receiving treatment as usual (TAU), and an intervention condition receiving TAU alongside an ACT self-help manual with weekly telephone support. The manual will be completed over six weeks. Both groups will be asked to complete questionnaires prior to intervention and 2 and 4 months post-intervention. Participants from each condition will be asked to participate in interviews to explore their experiences of taking part.

Interventions

OTHERSelf help book + telephone support

Self-help book based upon principles of Acceptance and Commitment Therapy

Sponsors

Nottingham University Hospitals NHS Trust
CollaboratorOTHER
University of Lincoln
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* undergoing haemodialysis treatment at one of three identified units * receiving haemodialysis treatment for more than 6 months * moderate depression (as indicated by the PHQ-9)

Exclusion criteria

* receiving concurrent psychological treatment * lacking mental capacity to consent due to cognitive impairment * inadequate reading ability (indicated by inability to complete PHQ-9 screening measure) * visual or hearing impairment that would prevent completion of the self-help book or engagement in telephone calls

Design outcomes

Primary

MeasureTime frameDescription
Change in Patient Health Questionnaire (PHQ-9) at 2 and 4 monthsBaseline; 2 months; 4 monthsValidated self-report questionnaire assessing symptoms of depression

Secondary

MeasureTime frameDescription
Change in EQ-5D-5L at 2 and 4 monthsBaseline; 2 months; 4 monthsValidated self-report questionnaire assessing health-related quality of life
Change in Acceptance and Action Questionnaire - 2 (AAQ-2) at 2 and 4 monthsBaseline; 2 months; 4 monthsValidated self-report questionnaire assessing psychological flexibility
Change in Valued Living Questionnaire (VLQ) at 2 and 4 monthsBaseline; 2 months; 4 monthsValidated self-report questionnaire assessing the extent to which individuals live consistently with their identified values

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026